Blue Earth Diagnostics

About Blue Earth Diagnostics

Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., is a growing international molecular imaging company focused on delivering innovative, well-differentiated diagnostic solutions that inform patient care. Formed in 2014, the Company’s success is driven by its management expertise and supported by a demonstrated track record of rapid development and commercialization of positron emission tomography (PET) radiopharmaceuticals. Blue Earth Diagnostics’ expanding oncology portfolio encompasses a variety of disease states, including prostate cancer and neuro-oncology. Blue Earth Diagnostics is committed to the timely development and commercialization of precision radiopharmaceuticals for potential use in imaging and therapy.

Website	http://www.blueearthdiagnostics.com/
Employees	51-200 employees View all Blue Earth Diagnostics employees
Industry	Pharmaceuticals
Headquarter	Magdalen Centre, The Oxford Science Park, Oxford, GB
Founded	2014
Keywords	Pet, Prostate Cancer, Medical Imaging, Radiology, Oncology, Nuclear Medicine, Cancer Diagnostics, Radiopharmaceuticals, Molecular Imaging, Cancer Imaging